Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US
Generate an AI Snapshot to get a quick, structured summary of this paper.
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Increasing access to sterile syringes through pharmacies requires the repeal or modification of legal barriers and is an inexpensive HIV prevention intervention with the potential to substantially reduce HIV transmission.
Abstract
Increasing access to sterile syringes through pharmacies requires the repeal or modification of legal barriers. Pharmacy sale of syringes to IDUs is an inexpensive HIV prevention intervention with the potential to substantially reduce HIV transmission. Further studies are needed to document how changes to legal barriers can influence HIV prevention for IDUs.
